These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8891915)

  • 41. Investigations on the stereoselectivity of the phase II metabolism of the 3,4-methylenedioxyethylamphetamine (MDEA) metabolites 3,4-dihydroxyethylamphetamine (DHEA) and 4-hydroxy-3-methoxyethylamphetamine (HMEA).
    Schwaninger AE; Meyer MR; Zapp J; Maurer HH
    Toxicol Lett; 2012 Jul; 212(1):38-47. PubMed ID: 22564759
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites by gas chromatography/mass spectrometry.
    Pizarro N; Llebaria A; Cano S; Joglar J; Farré M; Segura J; de la Torre R
    Rapid Commun Mass Spectrom; 2003; 17(4):330-6. PubMed ID: 12569443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gas chromatography-ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine.
    da Silva DG; de Pinho PG; Pontes H; Ferreira L; Branco P; Remião F; Carvalho F; Bastos ML; Carmo H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(9-10):815-22. PubMed ID: 20167546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug users.
    Kronstrand R
    J Anal Toxicol; 1996 Oct; 20(6):512-6. PubMed ID: 8889691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans.
    Abraham TT; Barnes AJ; Lowe RH; Kolbrich Spargo EA; Milman G; Pirnay SO; Gorelick DA; Goodwin RS; Huestis MA
    J Anal Toxicol; 2009 Oct; 33(8):439-46. PubMed ID: 19874650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse.
    Kikura R; Nakahara Y; Mieczkowski T; Tagliaro F
    Forensic Sci Int; 1997 Jan; 84(1-3):165-77. PubMed ID: 9042722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Designer drug 2,4,5-trimethoxyamphetamine (TMA-2): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
    Ewald AH; Fritschi G; Maurer HH
    J Mass Spectrom; 2006 Sep; 41(9):1140-8. PubMed ID: 16810708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid simultaneous determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine, 3,4-methylenedioxymethamphetamine, and 3,4-methylenedioxyethylamphetamine in urine by fast gas chromatography-mass spectrometry.
    Klette KL; Jamerson MH; Morris-Kukoski CL; Kettle AR; Snyder JJ
    J Anal Toxicol; 2005 Oct; 29(7):669-74. PubMed ID: 16419398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry.
    Staack RF; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Dec; 798(2):333-42. PubMed ID: 14643514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enantiomeric separation and quantitation of (+/-)-amphetamine, (+/-)-methamphetamine, (+/-)-MDA, (+/-)-MDMA, and (+/-)-MDEA in urine specimens by GC-EI-MS after derivatization with (R)-(-)- or (S)-(+)-alpha-methoxy-alpha-(trifluoromethy)phenylacetyl chloride (MTPA).
    Paul BD; Jemionek J; Lesser D; Jacobs A; Searles DA
    J Anal Toxicol; 2004 Sep; 28(6):449-55. PubMed ID: 15516295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of supercritical fluid extraction for the determination of amphetamines in hair.
    Allen DL; Oliver JS
    Forensic Sci Int; 2000 Jan; 107(1-3):191-9. PubMed ID: 10689572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid simultaneous determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine, 3,4-methylenedioxymethamphetamine, and 3,4-methylenedioxyethylamphetamine in urine by solid-phase extraction and GC-MS: a method optimized for high-volume laboratories.
    Stout PR; Horn CK; Klette KL
    J Anal Toxicol; 2002; 26(5):253-61. PubMed ID: 12166811
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adam and Eve make love. Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (MDE, "Eve") and its metabolite 3,4-methylenedioxyamphetamine (MDA) in rat brain.
    Tucker G
    Hum Exp Toxicol; 1996 May; 15(5):455-7. PubMed ID: 8735473
    [No Abstract]   [Full Text] [Related]  

  • 54. High-performance thin-layer chromatographic determination of N-ethyl-3,4-methylenedioxyamphetamine and its major metabolites in urine and comparison with high-performance liquid chromatography.
    Pisternick W; Kovar KA; Ensslin H
    J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(1):63-9. PubMed ID: 9029314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.
    Hegadoren KM; Baker GB; Bourin M
    Neurosci Biobehav Rev; 1999 Mar; 23(4):539-53. PubMed ID: 10073892
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of ephedrine, pseudoephedrine and phenylpropanolamine concentrations in human urine samples and a comparison of the specificity of DRI amphetamines and Abuscreen online (KIMS) amphetamines screening immunoassays.
    Stout PR; Klette KL; Horn CK
    J Forensic Sci; 2004 Jan; 49(1):160-4. PubMed ID: 14979364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecularly imprinted solid-phase extraction for the selective determination of methamphetamine, amphetamine, and methylenedioxyphenylalkylamine designer drugs in human whole blood by gas chromatography-mass spectrometry.
    Kumazawa T; Hasegawa C; Hara K; Uchigasaki S; Lee XP; Seno H; Suzuki O; Sato K
    J Sep Sci; 2012 Mar; 35(5-6):726-33. PubMed ID: 22271670
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Automated determination of 'Ecstasy' and amphetamines in urine by SPME and capillary gas chromatography after propylchloroformate derivatisation.
    Ugland HG; Krogh M; Rasmussen KE
    J Pharm Biomed Anal; 1999 Mar; 19(3-4):463-75. PubMed ID: 10704112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simultaneous Determination of Amphetamine-Related New Psychoactive Substances in Urine by Gas Chromatography-Mass Spectrometry.
    Kim JY; Suh S; Park J; In MK
    J Anal Toxicol; 2018 Nov; 42(9):605-616. PubMed ID: 29982540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative and qualitative analysis of MDMA, MDEA, MA and amphetamine in urine by headspace/solid phase micro-extraction (SPME) and GC/MS.
    Centini F; Masti A; Barni Comparini I
    Forensic Sci Int; 1996 Dec; 83(3):161-6. PubMed ID: 9032950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.